Atlas Trials

Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer

Clinical trial NCT00352872 · TERMINATED

Trial details

NCT number
NCT00352872
Sponsor
Indiana University
Status
TERMINATED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2005-02-01
Primary completion
2009-01-13
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.